Showing promise in the arena of weight management management, retatrutide presents a unique method. Different from many current medications, retatrutide works as a dual agonist, concurrently affecting both glucagon-like peptide-1 (GLP-1) and glucose-sensitive insulinotropic polypeptide (GIP) receptors. This dual activation fosters several helpful e